Research Topics
| Angela B MariottoSummaryAffiliation: National Institutes of Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Projecting SEER cancer survival rates to the US: an ecological regression approachAngela Mariotto
Department of Epidemiology, Istituto Superiore di Sanita, Rome, Italy
Cancer Causes Control 13:101-11. 2002..The objective of this study is to project cancer survival for the entire US as well as states from survival data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program...- The prevalence of patients with colorectal carcinoma under care in the U.SAngela Mariotto
Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 8317, USA
Cancer 98:1253-61. 2003..The objective of this study was to estimate the proportion of elderly patients with colorectal carcinoma (CRC) in the U.S. that actually were receiving care for their disease as a better quantification of the burden of CRC... 
Comparison of approaches for estimating incidence costs of care for colorectal cancer patientsK Robin Yabroff
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892, USA
Med Care 47:S56-63. 2009..The objective of this study was to compare 3 approaches for estimating the incidence costs of colorectal cancer (CRC) care using similar patient populations, but different data sources and methods...- Long-term survivors of childhood cancers in the United StatesAngela B Mariotto
National Cancer Institute, Bethesda, MD 20892 7344, USA
Cancer Epidemiol Biomarkers Prev 18:1033-40. 2009..To estimate the number of individuals in the United States diagnosed with cancer as children (ages 0-19 years) as of 2005, with a focus on those surviving for >30 years... - Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview SurveyAngela B Mariotto
Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
Cancer 109:1877-86. 2007..The objectives of this article were to reconstruct patterns of PSA testing between black and white men in the US and to determine the extent of any racial disparity in PSA use... - Multiple cancer prevalence: a growing challenge in long-term survivorshipAngela B Mariotto
Division of Cancer Control and Population Sciences, National Cancer Institute, 6116 Executive Boulevard, Suite 540, MSC 8317, Bethesda, MD 20892, USA
Cancer Epidemiol Biomarkers Prev 16:566-71. 2007..The present study was designed to estimate the number of and describe the pattern of disease among cancer survivors living with a history of multiple malignant tumors in the United States... - Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020Angela B Mariotto
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892, USA
Cancer Causes Control 17:1215-26. 2006..This study provides projections of colorectal cancer prevalence by phases of care (initial, monitoring, and last year of life) to the year 2020 and describes the estimation method... - Estimates of long-term survival for newly diagnosed cancer patients: a projection approachAngela B Mariotto
Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
Cancer 106:2039-50. 2006..The authors present a projection method that incorporates trends in survival and provides more up-to-date estimates of long-term survival for newly diagnosed patients... 
Projections of the cost of cancer care in the United States: 2010-2020Angela B Mariotto
Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892 7344, USA
J Natl Cancer Inst 103:117-28. 2011..Current estimates of the costs of cancer care in the United States are based on data from 2003 and earlier. However, incidence, survival, and practice patterns have been changing for the majority of cancers...- Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999Angela Mariotto
Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 8317, USA
J Natl Cancer Inst 94:1626-34. 2002..We evaluated trends in the use of adjuvant multi-agent chemotherapy, tamoxifen, and the combination of both treatments for early-stage breast cancer in the United States from 1975 through 1999... - Estimates and projections of value of life lost from cancer deaths in the United StatesK Robin Yabroff
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892 7344, USA
J Natl Cancer Inst 100:1755-62. 2008..Value-of-life methods are increasingly used in policy analyses of the economic burden of disease. The purpose of this study was to estimate and project the value of life lost from cancer deaths in the United States... - Breast cancer survivors in the United States: geographic variability and time trends, 2005-2015Roberta De Angelis
National Center of Epidemiology, Italian National Institute of Health, Rome, Italy
Cancer 115:1954-66. 2009..The current work represents a comprehensive collection of female breast cancer prevalence from 2005 to 2015 in the United States and the District of Columbia (DC)... - The Cancer Survival Query System: making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patientsEric J Feuer
Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA
Cancer 118:5652-62. 2012..However, registry data also can be used to calculate survival from cancer in the presence of competing risks, which is more clinically relevant... - Cancer survivors: a booming populationCarla Parry
Office of Cancer Survivorship, National Cancer Institute, NIH, Bethesda, MD 20892, USA
Cancer Epidemiol Biomarkers Prev 20:1996-2005. 2011..For this inaugural year, we focus on the confluence of the growing number of survivors and population aging, and the impact these combined trends will have on cancer survivorship in the future... - Improved estimates of cancer-specific survival rates from population-based dataNadia Howlader
Data Analysis and Interpretation Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 6116 Executive Blvd, Ste 504, Bethesda, MD 20892 8315, USA
J Natl Cancer Inst 102:1584-98. 2010..Because life tables for all subgroups in a study may be unavailable, we investigated whether cause-specific survival could be used as an alternative for relative survival... - Current and future utilization of services from medical oncologistsJoan L Warren
Applied Research Program, and the Surveillance Research Program, National Cancer Institute, Bethesda, MD 20892 7344, USA
J Clin Oncol 26:3242-7. 2008..This analysis assesses current utilization patterns and projects the number of people with cancer and their use of oncologists' services through 2020... - Adverse events after outpatient colonoscopy in the Medicare populationJoan L Warren
National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Ann Intern Med 150:849-57, W152. 2009..Although use of colonoscopy has increased substantially among elderly Medicare beneficiaries, no one has described colonoscopy-related adverse events in a representative sample of Medicare patients... - Projections of the costs associated with colorectal cancer care in the United States, 2000-2020K Robin Yabroff
Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 6130 Executive Boulevard, Bethesda, MD 10892, USA
Health Econ 17:947-59. 2008..The future economic burden of colorectal cancer to the Medicare program and its beneficiaries in the US will be substantial... - Cancer Survivors in the United States: Prevalence across the Survivorship Trajectory and Implications for CareJanet S de Moor
Corresponding Author Janet S de Moor, Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute NIH, 6116 Executive Boulevard, Suite 404, Bethesda, MD 20892
Cancer Epidemiol Biomarkers Prev 22:561-70. 2013..To inform survivorship research and practice, this manuscript will describe the prevalent population of cancer survivors in terms of overall numbers and prevalence by cancer site and time since diagnosis... - Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?Lan Huang
Statistical Research and Applications Branch, Surveillance Research Program, National Cancer Institute, Bethesda, Maryland 20892, USA
Cancer 112:2289-300. 2008.... - Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality ratesEric J Feuer
Statistical Research and Applications Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 8317, USA
Cancer 95:870-80. 2002..In this article, the authors model the potential impact of this stage shift on prostate carcinoma mortality rates given various assumptions concerning the survival of patients with screen-detected local-regional disease... - The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testingEric J Feuer
Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA
Stat Methods Med Res 13:421-42. 2004..Some of the models presented here were developed as part of the National Cancer Institute's Cancer Intervention and Surveillance Modeling Network... - Geographic association between mammography use and mortality reduction in the USBarnali Das
Statistical Research and Applications Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892, USA
Cancer Causes Control 16:691-9. 2005.... - Cost of care for elderly cancer patients in the United StatesK Robin Yabroff
Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North, Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
J Natl Cancer Inst 100:630-41. 2008..We estimated net costs of care for elderly cancer patients in the United States for the 18 most prevalent cancers and for all other tumor sites combined... - Burden of illness in adult survivors of childhood cancers: findings from a population-based national sampleEmily Dowling
Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 7344, USA
Cancer 116:3712-21. 2010..The purpose of this study was to use a national, population-based sample to estimate the burden of illness in adult survivors of childhood cancer... - Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?K Robin Yabroff
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Med Care 47:S64-9. 2009.... - Estimating complete prevalence of cancers diagnosed in childhoodArianna Simonetti
National Center for Epidemiology, Surveillance and Health Promotion, Department of Cancer Epidemiology, Istituto Superiore di Sanita, Viale Regina Elena 299, Rome, Italy
Stat Med 27:990-1007. 2008..Results of complete childhood prevalence estimates based on SEER-9 cancer registries data for acute lymphocytic leukemia and all cancer sites combined are presented...